Status:

RECRUITING

Luminal Fructose Kinetics (MARTINI Study)

Lead Sponsor:

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Conditions:

MASLD

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

Brief Summary

In this study the investigators aim is to explore the dynamics of (small) intestinal fructose catabolism in humans and ethanol production in relation to small intestinal signalling pathways and change...

Detailed Description

The investigators will perform a non blinded single centre intervention study in 2x 11 participants Participants will be either healthy volunteers with a BMI \< 25 and Age 18-65 or patients with MASL...

Eligibility Criteria

Inclusion

  • In case of the healthy subject group:
  • Adult individuals, age \> 18 \<65 years
  • Male or postmenopauzal females
  • BMI \<25
  • Ability to give informed consent In case of the MASLD/MASH group
  • Adult individuals, age \> 18 \<65 years
  • Male or postmenopauzal females
  • BMI \> 25
  • Biopsy proven MASLD/MASH
  • Ability to give informed consent

Exclusion

  • History of sustained excess alcohol ingestion: daily consumption \>30g/day (3 drinks per day) for males and \>20 g/day (2 drinks per day) for females
  • Patients with diabetes
  • Bariatric surgery
  • Other forms of liver disease (e.g. Hepatitis B,C, Wilson disease, hemochromatosis)
  • Proton-pump inhibitor usage one year prior to study participation
  • GLP1, SGLT2i or insulin use
  • Antibiotic use for the past 3 months
  • Probiotic or symbiotic usage
  • Pregnant women
  • Chronic illness (including a known history of heart failure, renal failure (eGFR \<30 ml/min), pulmonary disease, gastrointestinal disorders, or hematologic diseases), or other inflammatory diseases
  • Active infection
  • Use of ascal, clopidogrel or other platelet inhibition
  • Smoking
  • Blood thinners
  • Heart failure

Key Trial Info

Start Date :

July 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2026

Estimated Enrollment :

22 Patients enrolled

Trial Details

Trial ID

NCT06539494

Start Date

July 1 2024

End Date

April 1 2026

Last Update

August 6 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Amsterdam UMC location AMC

Amsterdam, Netherlands